If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

  • This share is currently suspended. It was suspended at a price of 13.60

Share Price Information for Clean Power Hyd (CPH2)

Share Price is delayed by 15 minutes
Get Live Data
13.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £68.27m
CPH2 Live PriceLast checked at - London Stock Exchange

Intraday Clean Power Hyd Share Chart

Manufacturing Partnership with Kenera

27 Jun 2025 07:00

RNS Number : 6543O
Clean Power Hydrogen
27 June 2025
 

27 June 2025

 

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

 

CPH2 Activates Licenced Manufacturing Partnership with Kenera

 

 

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce the submission of its manufacturing and design licence documentation ("licence package") to its licensee Kenera, a Helmerich & Payne ("H&P") Company.

 

The licence pack will allow Kenera to review the final MFE design packages and system assemblies in order for the teams to begin the process of building the first MFE electrolysers under its agreement. The full document pack includes: Process, Mechanical, Electrical and Safety Design Package; Bill of materials with every part defined; 3D layout defined for the electrolyser and all sub-assemblies.

 

CPH2 has granted Kenera a non-exclusive licence to sell and manufacture CPH2 products in Germany, Scotland, Azerbaijan, Denmark and Norway as well as an exclusive licence to sell and manufacture CPH2 products across the Middle East up to a maximum level of 2GW (including Oman, Saudi Arabia, United Arab Emirates, Qatar, Kuwait and Iraq).

 

Kenera can now begin the process of planning to commence production. The Kenera and CPH2 teams will continue to work closely together focused on the transfer of MFE design, assembly and testing requirements, as well as completing, staff training, supplier onboarding and production line readiness.

 

 

Jon Duffy, CEO of Clean Power Hydrogen commented:

"Activating our licence with Kenera through the submission of this licence package is a significant achievement and maintains the flow of progress in the deployment of our licence model, which aims to quickly scale the utilisation of our MFE technology. We look forward to working with Kenera to advance its build and have another MFE unit operational in the field."

 

 

Rebecca Clarke, SVP Kenera commented:

"We are delighted to have received the licence pack. We are keen to begin production as soon as it is feasibility possible and will work with CPH2 to expedite this."

 

 

 

 

ENDS

 

 

For more information, please contact:

 

Clean Power Hydrogen plc

via Camarco

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

Cavendish Capital Markets Limited - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 20 3 757 4980

Owen Roberts

Kirsty Duff

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGZVGVZGKZZ
Date   Source Headline
16th Jan 20259:21 amRNSIssue of Ordinary Shares
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
8th Jan 202512:02 pmRNSResult of General Meeting and Total Voting Rights
20th Dec 20245:11 pmRNSResults of Retail Offer
19th Dec 20247:00 amRNSResult of Placing and Subscription
18th Dec 20245:09 pmRNSRetail Offer for up to £0.3 million
18th Dec 20244:42 pmRNSProposed Placing, Subscription, and Retail Offer
26th Nov 20247:00 amRNSOperational Update and Proposed Fundraising
7th Nov 20243:22 pmRNSNotification of Major Shareholdings
4th Nov 20247:00 amRNSSettlement with GHFG
4th Nov 20247:00 amRNSNew Licence Agreement and Sales Contract
15th Oct 20247:00 amRNSRenewed Contract Terms for MFE220 Sales Contracts
27th Sep 20247:00 amRNS2024 Interim Results
26th Sep 20247:00 amRNSFactory Acceptance Test for MFE110 electrolyser
5th Sep 20247:38 amRNSPublication of Interim Results
15th Aug 20247:00 amRNSLevel 2 Factory Acceptance Test Completed
29th Jul 20247:00 amRNSTR-1: Notification of major holdings
26th Jul 20247:00 amRNSTR-1:Notification of major holdings
3rd Jul 20247:00 amRNSExercise of Options - Issue of Equity
28th Jun 20248:10 amRNSLevel 1 of Factory Acceptance Test Completed
19th Jun 20245:34 pmRNSResult of AGM
18th Jun 20247:00 amRNSCE Marking Awarded
12th Jun 20247:00 amRNSHoldings in Company
23rd May 20247:00 amRNS2024 Save as You Earn Scheme
10th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
19th Apr 20247:00 amRNS2023 Full Year Results
23rd Feb 20247:00 amRNSAwards under Long-Term Incentive Plan
21st Feb 20247:00 amRNSOperational Update
5th Feb 20247:00 amRNSISO Certifications
28th Nov 20237:00 amRNSRevised Agreement with ATOME Energy
20th Nov 20237:00 amRNSChange of Nominated Adviser
2nd Nov 20237:00 amRNSCompany Update
21st Sep 20237:00 amRNSInterim Results
22nd Jun 20237:00 amRNS2023 Save As You Earn Scheme
21st Jun 20231:09 pmRNSResult of AGM
19th Jun 20237:00 amRNSGrant of EMI Options
6th Jun 20237:00 amRNSUpdate on Licence Agreement with GHFG Limited
17th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
28th Apr 202312:16 pmRNSHoldings in Company
26th Apr 20233:26 pmRNSPDMR Dealing
25th Apr 20237:00 amRNSCorporate Presentation
20th Apr 20237:00 amRNSMaiden Financial Results
13th Apr 20237:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.